InfinityCoat™ for tomorrow's tablets

Chitin nanofiber barrier coating
for commercial tablets

Carapex InfinityCoat™ is a next-generation pharmaceutical tablet coating that delivers an industry-leading barrier against oxygen and moisture to dramatically extend shelf life — without changing existing coating workflows.

Industry-leading O₂ & moisture barrier

Up to 120% shelf-life extension target

Comparable or lower cost per pill

Sustainably sourced chitin nanofibers

No more plastic pills

InfinityCoat™

Tablet coating & shelf-life barrier film

Greener, cheaper, healthier

01 • Stability & shelf life

Extend shelf life at the barrier

InfinityCoat™ forms dense, transparent films that slow oxygen-driven oxidation and moisture-driven hydrolysis — with a conservative shelf-life extension target of up to 120%.

02 • Economics & supply chain

Reduce expiry-driven write-offs

Globally, an estimated $33B of medicine expires before it can be used. By extending stability windows, InfinityCoat™ reduces waste, lowers re-manufacturing pressure, and helps manufacturers, healthcare providers, and consumers capture more value from every batch.

03 • Sustainability

Cut waste and plastic reliance

InfinityCoat™ is made from chitin nanofibers sourced from recycled organic material like crustacean shells or mushrooms. Longer shelf life can also reduce dependence on plastic blister packaging across the supply chain.

Products & Solutions

InfinityCoat™ tablet coatings engineered for barrier performance

InfinityCoat™ is a chitin nanofiber-based film coating designed to block oxygen and moisture — the two primary drivers of API degradation. We plan to sell our formulation to pharmaceutical manufacturers and CDMOs, designed to run on existing pan and fluid-bed coaters with minimal workflow disruption.

InfinityCoat™ Film Formulation

Chitin nanofiber-based tablet coating engineered for industry-leading oxygen and moisture barrier performance.

Compatible with standard pan and fluid-bed coaters
Tunable film thickness and permeability targets
Digestible, antimicrobial biomaterial backbone

Tech Transfer & Scale-Up Packages

Formulation handoff designed to fit manufacturer workflows — from pilot trials through commercial validation.

Process parameters aligned to existing infrastructure
Stability study design for oxygen/moisture-sensitive APIs
Documentation support for quality and regulatory teams

Barrier & Stability Characterization

Performance testing that quantifies oxygen/moisture transmission, film integrity, and real-world shelf-life impact.

OTR/WVTR benchmarking against incumbent films
Accelerated aging and storage-condition mapping
Data packages to support adoption decisions

Applications

Built for tablet manufacturers, CDMOs, and innovators

InfinityCoat™ is designed for pharmaceutical manufacturers and CDMOs looking to extend tablet shelf life, reduce expiry-driven waste, and improve sustainability — without changing coating infrastructure.

Shelf-Life Extension

Increase stability for oxygen-sensitive and moisture-sensitive tablet formulations.

Moisture & Oxygen Sensitive APIs

Slow oxidation and hydrolysis by limiting oxygen and water ingress through the coating film.

Packaging Reduction

Longer shelf life can reduce dependence on plastic blister packaging and cold-chain constraints.

Sustainable Consumer Health

Enable lower-waste tablet coatings for OTC and consumer health products using sustainably sourced chitin nanofibers.

Manufacturing & Compliance

Tablet-coating processes designed around GMP expectations

From pilot runs to commercial scale, InfinityCoat™ is designed to run on standard tablet-coating equipment to minimize disruption while lifting barrier performance.

GMP-aligned chitin nanofiber preparation and characterization
Compatibility with standard pan and fluid-bed coating workflows
Process windows for coating weight gain and film integrity
Documentation packages to support quality and regulatory adoption

Research & Development

Translational chitin science for tablet-coating films

Our R&D programs focus on how chitin nanofiber film structure drives oxygen/moisture barrier performance — translating directly into predictable shelf-life gains.

Structure–function mapping across chitin nanofiber film architectures
Pilot collaborations with tablet manufacturers and CDMOs
Benchmarking versus incumbent vinyl-based barrier films
Models that link barrier metrics to stability and expiry outcomes

Company & Collaborations

Partnering at the intersection of biomaterials and pharmaceutical manufacturing

Carapex is a chitin-focused pharma technology company developing InfinityCoat™ — a next-generation tablet coating designed to block oxygen and moisture, the primary drivers of API degradation and expiry-driven waste.

We will work with pharmaceutical manufacturers and CDMOs through feasibility, pilot trials, and scale-up. We do not coat tablets ourselves — we sell our formulation so partners can run InfinityCoat™ on existing coating infrastructure.

Current partner

Leadership

Meet the Carapex leadership

Elizabeth Lim

Project Management & Business Strategy

Ryan Parissay

Project Management & Business Strategy

Peter Van Den Doel

Research Engineer

Darren A. Hartono

Marketing & Outreach Lead

Hashaam Zafar

Hardware Engineer

Kavian Aldavoud

Biological Science & Digital Systems Lead

Martin Edwini-Bonsu

Process Engineer